ArticleFrontiers in public health2024

Impact of National Centralized Drug Procurement policy on chemical pharmaceutical enterprises' R&D investment: a difference-in-differences analysis in China.

Jiaming Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.